MECP2 and Angelman syndrome: The 2025 AAP clinical report offers a structured algorithm integrating comprehensive history-taking, physical examination, CMA, ES/GS, and phenotype-directed assays such as methylation testing for Prader–Willi or Angelman syndromes, and MECP2 analysis in girls with Rett-like regression [34,35].